Abstract
Objective
Vulvar and vaginal cancers are rare diseases with an incidence rate that increases with age. At present, epidemiological data are rather scarce. This review article provides an epidemiologic overview of these diseases, focussing on recent German data.
Methods
This review article summarizes the information currently available in order to offer an epidemiologic overview.
Results
The statistic incidence of vulvar carcinoma has been calculated between 2 and 7 cases per 100,000 women, and that of vaginal carcinoma 0.6–1.0 cases per 100,000 women. These incidence rates, especially concerning intraepithelial neoplasm, have increased heavily since the 1970s. The mean age of vulvar cancer affection is 72 years, and 74 years for vaginal carcinoma. In the case of women below the age of 50, cancer tends to be HPV-associated which implies a coincidence of about 20% for cervical and anal cancer. Various pathological mechanisms are the cause for women above the age of 50.
Conclusions
Due to a change in sexual behavior and an increased rate of HPV infection among younger women, increased incidence of both diseases has to be expected. The age-standardized mortality rate of vulvar carcinoma in Europe is stated at 0.7/100,000 women, and that of vaginal carcinoma at 0.4/100.000 women. To what extent the HPV-vaccination affects incidence and mortality rates is continually being observed.
Similar content being viewed by others
References
Judson PL, Habermann EB, Baxter NN et al (2006) Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107(5):1018–1022
Sturgeon SR, Curtis RE, Johnson K et al (1996) Second primary cancers after vulvar and vaginal cancer. AMJ Obstet Gynecol 174(3):929–933
Joura EA, Lösch A, Haider-Angeler MG et al (2000) Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J Reprod Med 45(8):613–615
Brinton LA, Nasca PC, Mallin K et al (1990) Case–control study of cancer of the vulva. Obstet Gynecol 75(5):859–866
Daling JR, Sherman KJ, Hislop TG et al (1992) Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 135(2):180–189
Sturgeon SR, Brinton LA, Devesa SS et al (1992) In situ, invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 166(5):1482–1485
Madeleine MM, Daling JR, Carter JJ et al (1997) Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 89(20):1516–1523
Santos M, Montagut C, Mellado B et al (2004) Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 23(3):206–214
Informationszentrum für Standards in der Onkologie—ISTO: Interdisziplinäre Kurzgefasste Leitlinien der Deutschen Krebsgesellschaft und der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe, AWMF-Leitlinienregister 032-032, 2001
Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207–225
Mandelblatt JS, Kanetsky P, Eggert L et al (1999) Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 8(1):97–106
Engel J, Schmidt M, Schubert-Fritschle G (Hrg.) Tumorregister München: Jahresbericht 1999, Zuckschwerdt Verlag Germering
Al-Ghamdi A, Freedman D, Miller D et al (2002) Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases. Gynecol Oncol 84(1):94–101
Hording U, Daugaard S, Junge J et al (1996) Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 15(3):230–234
Bjørge T, Dillner J, Anttila T et al (1997) Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ. 315(7109):646–649
Santos M, Landolfi S, Olivella A et al (2004) p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 30(11):1347–1356
Sigvardsson S, Hardell L, Przybeck TR et al (1996) Increased cancer risk among Swedish female alcoholics. Epidemiology 7(2):140–143
Daling JR, Chu J, Weiss NS et al (1984) The association of condylomata acuminata and squamous carcinoma of the vulva. Br J Cancer 50(4):533–535
Koyamatsu Y, Yokoyama M, Nakao Y et al (2003) A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol Oncol 90(3):547–551
Rolfe KJ et al (2003) TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 89(12):2249–2253
Mardh PA (1991) The vaginal ecosystem. Am J Obstet Gynecol 165:1163–1168
Ries LAG, Kossary CL, Hankey BF et al (1998) SEER Cancer statistics Review, 1973–1995. National Cancer Institute, Bethesda
Beller U, Sideri M, Maisonneuve P et al (2001) Carcinoma of the vagina. J Epidemiol Biostat 6(1):141–152
Fu YS (2002) Pathology of the uterine cervix, vagina, and vulva, 2nd edn. Saunders, Philadelphia, p 531
Creasman WT, Phillips JL, Menck HR (1998) The National cancer data base report on cancer of the vagina. Cancer 83:1033
Herbst AL, Ulfelder H, Poskanzer DC et al (1991) Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. 1971. Am J Obstet Gynecol 181(6):1574–1575
Carter JJ et al (2001) Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites. Cancer Res 61(5):1934–1940
Daling JR, Madeleine MM, Schwartz SM et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270
Hampl M et al (2006) Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer. Obstet Gynecol 108(6):1361–1368
Madsen BS et al (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina–population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834
Wassberg C et al (1999) Second primary cancers in patients with squamous cell carcinoma of the skin: a population-based study in Sweden. Int J Cancer 80(4):511–515
Benedet JL, Murphy KJ, Fairey RN et al (1983) Primary invasive carcinoma of the vagina. Obstet Gynecol 62(6):715–719
Eddy GL, Marks RD, Miller MC et al (1991) Primary invasive vaginal carcinoma. Am J Obstet Gynecol 165(2):292–296
Frisch M, Olsen JH, Melbye M (1994) Malignancies that occur before and after anal cancer: clues to their etiology. Am J Epidemiol 140(1):12–19
Hussain SK et al (2008) Familial clustering of cancer at human papillomavirus-associated sites according to the Swedish family-cancer database. Int J Cancer 122(8):1873–1878
Parazzini F et al (1995) Selected food intake and risk of vulvar cancer. Cancer 76(11):2291–2296
Basta A, Adamek K, Pitynski K (1999) Intraepithelial neoplasia and early stage vulvar cancer. Epidemiological, clinical and virological observations. Eur J Gynaecol Oncol 20(2):111–114
Trimble CL et al (1996) Heterogeneous etiology of squamous carcinoma of the vulva. Obstet Gynecol 87(1):59–64
Baumann KH, Müller O, Naujok HB et al (2010) Small-area analysis of incidence and localisation of vulvar cancer. J Oncol 2010:512032
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dittmer, C., Katalinic, A., Mundhenke, C. et al. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet 284, 169–174 (2011). https://doi.org/10.1007/s00404-011-1850-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-011-1850-9